Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Neosartorya fischeri Protein fyv10 (fyv10) CSB-YP373108NEZ
CSB-EP373108NEZ
CSB-BP373108NEZ
CSB-MP373108NEZ
CSB-EP373108NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Long chronological lifespan protein 2 (lcl2) CSB-YP373109NEZ
CSB-EP373109NEZ
CSB-BP373109NEZ
CSB-MP373109NEZ
CSB-EP373109NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Probable alpha-galactosidase B (aglB) CSB-YP373110NEZ
CSB-EP373110NEZ
CSB-BP373110NEZ
CSB-MP373110NEZ
CSB-EP373110NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Probable beta-glucosidase M (bglM), partial CSB-YP373111NEZ
CSB-EP373111NEZ
CSB-BP373111NEZ
CSB-MP373111NEZ
CSB-EP373111NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Probable endopolygalacturonase NFIA_008150 (NFIA_008150) CSB-YP373112NEZ
CSB-EP373112NEZ
CSB-BP373112NEZ
CSB-MP373112NEZ
CSB-EP373112NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri ADP-ribose 1'-phosphate phosphatase (poa1) CSB-YP373113NEZ
CSB-EP373113NEZ
CSB-BP373113NEZ
CSB-MP373113NEZ
CSB-EP373113NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Probable alpha/beta-glucosidase agdC (agdC), partial CSB-YP373114NEZ
CSB-EP373114NEZ
CSB-BP373114NEZ
CSB-MP373114NEZ
CSB-EP373114NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Protein dml1 (dml1), partial CSB-YP373115NEZ
CSB-EP373115NEZ
CSB-BP373115NEZ
CSB-MP373115NEZ
CSB-EP373115NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Probable Xaa-Pro aminopeptidase NFIA_010500 (NFIA_010500) CSB-YP373116NEZ
CSB-EP373116NEZ
CSB-BP373116NEZ
CSB-MP373116NEZ
CSB-EP373116NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Mitochondrial distribution and morphology protein 12 (mdm12) CSB-YP373117NEZ
CSB-EP373117NEZ
CSB-BP373117NEZ
CSB-MP373117NEZ
CSB-EP373117NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Probable mannosyl-oligosaccharide alpha-1,2-mannosidase 1B (mns1B) CSB-YP373118NEZ
CSB-EP373118NEZ
CSB-BP373118NEZ
CSB-MP373118NEZ
CSB-EP373118NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Probable beta-galactosidase A (lacA), partial CSB-YP373119NEZ
CSB-EP373119NEZ
CSB-BP373119NEZ
CSB-MP373119NEZ
CSB-EP373119NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Pentafunctional AROM polypeptide (aroM), partial CSB-YP373120NEZ
CSB-EP373120NEZ
CSB-BP373120NEZ
CSB-MP373120NEZ
CSB-EP373120NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Mitogen-activated protein kinase hog1 (hog1) CSB-YP373121NEZ
CSB-EP373121NEZ
CSB-BP373121NEZ
CSB-MP373121NEZ
CSB-EP373121NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Catabolic 3-dehydroquinase 1 (qutE1) CSB-YP373122NEZ
CSB-EP373122NEZ
CSB-BP373122NEZ
CSB-MP373122NEZ
CSB-EP373122NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Pre-mRNA-processing ATP-dependent RNA helicase prp5 (prp5), partial CSB-YP373123NEZ
CSB-EP373123NEZ
CSB-BP373123NEZ
CSB-MP373123NEZ
CSB-EP373123NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Nitrogen permease regulator 3 (npr3), partial CSB-YP373124NEZ
CSB-EP373124NEZ
CSB-BP373124NEZ
CSB-MP373124NEZ
CSB-EP373124NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Ribosome biogenesis protein ERB1 (erb1), partial CSB-YP373125NEZ
CSB-EP373125NEZ
CSB-BP373125NEZ
CSB-MP373125NEZ
CSB-EP373125NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Probable cytosolic iron-sulfur protein assembly protein 1 (cia1) CSB-YP373126NEZ
CSB-EP373126NEZ
CSB-BP373126NEZ
CSB-MP373126NEZ
CSB-EP373126NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neosartorya fischeri Histone H2A.Z-specific chaperone chz1 (chz1) CSB-YP373127NEZ
CSB-EP373127NEZ
CSB-BP373127NEZ
CSB-MP373127NEZ
CSB-EP373127NEZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>